门静脉高压治疗现状与展望  

Current Status and Prospect of Portal Hypertension

作　　者：车小双[1] 彭心宇[1] 张示杰[1] 吴向未[1] 吕海龙[1] 

机构地区：[1]石河子大学医学院,新疆石河子832000

出　　处：《现代生物医学进展》2013年第5期994-997,共4页Progress in Modern Biomedicine

摘　　要：门静脉高压症是一种主要因肝脏病变而引起门静脉系统循环异常为主要特点的病症,经过100多年的研究与探索,门静脉高压症的诊断和治疗手段均得到了不断的发展和完善。如非选择性β受体阻断剂和内镜下曲张静脉套扎术对预防有中、重度静脉曲张的患者首次静脉曲张出血均具有各自的优势,气囊阻断经静脉逆行栓塞术对曲张的食管胃底静脉的具有良好疗效,部分性脾栓塞术已成为肝硬化门脉高压脾亢血液病的最主要非手术治疗措施,外科治疗方面联合手术的优势已经逐步体现出来,但门静脉高压症最根本的治疗措施仍是肝移植。但选择何种方式治疗,仍要根据患者肝功能状况及病情变化而定,本文将就门静脉高压治疗现状与展望做一综述。Portal hypertension is a major liver lesions caused by abnormal portal venous system circulation as the main features of the syndrome.After 100 years of research and exploration,diagnosis and treatment of patients with portal hypertension has also been a constant improvement and innovation.Non-selective beta block-ers in preventing first variceal hemorrhage has the exact effect in patients with moderate to severe esophageal va-rices,EVL has its unique advantages in the prevention of first hemorrhage,Balloon occluded retrograde transve-nous obliteration（B-RTO）＇s clear efficacy of the treatment of esophageal and gastric varicose vein will win the re-cognition of the growing number of scholars.Partial splenic embolization（PSE） has been increasingly performed as a non-surgical treatment by IVR procedure for the treatment of hematological disorders caused by hyperspleni-sm.Surgical treatment： The advantages of combined surgery has been gradually reflected.But the most fundamental treatment is liver transplantation.To choose which way to treat,is still based on the change of the status and con-dition of the liver function in patients,Specific various treatment and remedial treatment of choice is still worthy of exploration and research.

关 键 词：门静脉高血症 非选择性β阻断剂 气囊阻断经静脉逆行栓塞术 部分性脾栓塞术 肝移植 

分 类 号：R575.21[医药卫生—消化系统]